ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,231,533 | -28.8% | 4,180,768 | 0.0% | 0.41% | -16.4% |
Q2 2023 | $27,007,761 | -14.3% | 4,180,768 | 0.0% | 0.49% | -21.0% |
Q1 2023 | $31,522,991 | -25.6% | 4,180,768 | 0.0% | 0.62% | -23.6% |
Q4 2022 | $42,351,180 | +2.4% | 4,180,768 | 0.0% | 0.81% | +5.5% |
Q3 2022 | $41,348,000 | -12.4% | 4,180,768 | -5.6% | 0.77% | -10.2% |
Q2 2022 | $47,188,000 | +15.8% | 4,430,768 | +6.0% | 0.86% | +29.3% |
Q1 2022 | $40,762,000 | -31.8% | 4,180,768 | 0.0% | 0.66% | -14.0% |
Q4 2021 | $59,785,000 | -28.6% | 4,180,768 | 0.0% | 0.77% | -16.5% |
Q3 2021 | $83,783,000 | -38.8% | 4,180,768 | -32.8% | 0.92% | -33.5% |
Q2 2021 | $136,906,000 | -50.8% | 6,223,019 | -24.1% | 1.38% | -46.8% |
Q1 2021 | $278,498,000 | -17.6% | 8,200,768 | -2.4% | 2.60% | -12.0% |
Q4 2020 | $338,047,000 | – | 8,400,768 | – | 2.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |